Pericarditis

·MeSH: Recurrence

6 drugs in development·5 companies·2 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
arcalyst	X4 Pharmaceuticals, Inc (XFOR)
ARCALYST	Kiniksa Pharmaceuticals International, plc (KNSA)

Phase 2(2)

Drug	Company
CardiolRx	Cardiol Therapeutics Inc. (CRDL)
vtx2735	Ventyx Biosciences, Inc. (VTYX)

Phase 1(1)

Drug	Company
mRNA-1273	Moderna, Inc. (MRNA)

Phase 2/Phase 3(1)

Drug	Company
KPL-387	Kiniksa Pharmaceuticals International, plc (KNSA)

BioSniper tracks 6 drugs in development for Pericarditis across 5 companies.

There are 2 clinical trials targeting Pericarditis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.